BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Loading...
Loading...

amgen peptibodies Pages on BioPortfolio:

BioPortfolio - department of early development medical sciences amgen
Recent Search Terms used to find this page: department of early development medical sciences amgen | amgen peptibodies | amgen VAT | non inferiority trials
...
http://www.bioportfolio.com/search/department_of_early_devel...

BioPortfolio - Amgen Incorporated
15 Nov 2008 ... With expertise in proteins, small molecules, antibodies, peptibodies, and nucleic acids, Amgen’s scientists can pursue the study of disease, ...
http://www.bioportfolio.com/biocorporate/711-Amgen_Incorpora...

Smaller is better for thrombopoiesis-stimulating agents
The two macromolecular proteins are a recombinant human thrombopoietin having completed clinical development in China and Amgen’s “peptibody” protein AMG ...
http://www.bioportfolio.com/biotech_news/lamerie_1.htm...

Amgen - The Biotech Leader - Market Analyses and Outlook, 2008-2023
2.1 Amgen is a Major Player in The World Pharmaceutical Market 3. Company Overview .... 10.5.3 AMG 386 a recombinant Fc-Peptide Fusion Protein (Peptibody)
...
http://www.bioportfolio.com/cgi-bin/acatalog/info_391.html...

Results from other life science and pharmaceutical sites:

Amgen - Search Results
Peptibodies are engineered ... more >. 17. Amgen - Medical Professionals ... Romiplostim, Amgen's first peptibody, is a novel engineered therapeutic fusion
...
http://www.amgen.com/searchresults.jsp?resultsPerPage=12&sea...

BioPortfolio - department of early development medical sciences amgen
Recent Search Terms used to find this page: department of early development medical sciences amgen | amgen peptibodies | amgen VAT | non inferiority trials
...
http://www.bioportfolio.com/search/department_of_early_devel...

Amgen - Media - Press Release
12 Mar 2008 ... Developed by Amgen, peptibodies are engineered therapeutic molecules that can bind to human drug targets and contain peptides linked to the ...
http://www.amgen.com/media/media_pr_detail.jsp?releaseID=111...

Amgen's TPO mimic faces stiff competition - Nature Biotechnology
To create the AMG 531 peptibody, Amgen combined its preselected peptide with a carrier molecule that extends the life of the drug in the patient's ...
http://www.nature.com/nbt/journal/v24/n9/full/nbt0906-1044.h...

Amgen - Media - Virtual Press Kits - RANKL Ligand
The peptibody is a novel platform developed by scientists at Amgen. A peptibody is an engineered protein, made by recombinant DNA technology, ...
http://www.amgen.com/media/virtual_press_kits.html...

AACR-NCI-EORTC - 17th Symposium: Molecular Targets and Cancer ...
confirmed that the peptibody angiopoietin antagonist. AMG-386 (Amgen Inc) is currently in phase I clinical trials. Novel antibody-based therapeutics ...
http://www.biomedcentral.com/content/pdf/cd-642363.pdf...

Amgen - Search Results
Amgen - Media - Virtual Press Kits - RANKL Ligand ... and antibodies, but is distinct from each. The Nplate peptibody protein has been designed to bind to
...
http://www.amgen.com/searchresults.jsp?resultsPerPage=12&sea...

BioPortfolio - Amgen Incorporated
15 Nov 2008 ... With expertise in proteins, small molecules, antibodies, peptibodies, and nucleic acids, Amgen’s scientists can pursue the study of disease, ...
http://www.bioportfolio.com/biocorporate/711-Amgen_Incorpora...

Amgen - Media - Press Release
"AMG 531 is Amgen's first peptibody and represents a new approach to potentially treat immune thrombocytopenic purpura (ITP), an autoimmune bleeding ...
http://www.amgen.com/media/media_pr_detail.jsp?releaseID=650...

FDA Approves Amgen's Nplate(TM) for Long-Term Treatment of Adult ...
25 Aug 2008 ... Nplate, Amgen’s first peptibody protein, is a novel engineered therapeutic fusion protein with attributes of both peptides and antibodies, ...
http://www.biospace.com/news_story.aspx?NewsEntityId=107681...

Google Custom Search

Search
  

  Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2008 - BioPortfolio Limited.